We are live on ! Find out more
CH

CVS Health Portfolio holdings

AUM $225M
1-Year Est. Return 8.77%
This Fund
S&P 500
This Quarter Est. Return
+0.58%
1 Year Est. Return
+8.77%
3 Year Est. Return
+48.72%
5 Year Est. Return
10 Year Est. Return
AUM
$225M
AUM Growth
+$12.9M
Cap. Flow
+$12.4M
Cap. Flow %
5.52%
Top 10 Hldgs %
83.7%
Holding
37
New
4
Increased
7
Reduced
1
Closed
16
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGSB icon
1
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$46.6M 20.72%
890,000
+595,600
+202% +$31.2M
IGIB icon
2
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.7B
$23.4M 10.39%
440,000
+347,250
+374% +$18.5M
IEI icon
3
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$21.5M 9.54%
182,800
SHY icon
4
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$21.2M 9.41%
258,100
+25,000
+11% +$2.06M
USHY icon
5
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
$17.7M 7.86%
478,100
+130,000
+37% +$4.81M
EMB icon
6
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.8B
$17.4M 7.71%
180,000
+73,000
+68% +$6.99M
AGG icon
7
iShares Core US Aggregate Bond ETF
AGG
$139B
$14.8M 6.58%
149,700
VCSH icon
8
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$9.48M 4.21%
120,000
IGLB icon
9
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
$8.76M 3.89%
175,000
+75,000
+75% +$3.74M
LQD icon
10
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.3B
$7.63M 3.39%
+70,000
New +$7.63M
HYG icon
11
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
$7.2M 3.2%
+90,000
New +$7.2M
VGIT icon
12
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.5B
$5.01M 2.23%
85,000
JAAA icon
13
Janus Henderson AAA CLO ETF
JAAA
$30.1B
$4.99M 2.22%
98,795
JPST icon
14
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
$4.98M 2.21%
98,500
VCIT icon
15
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
$4.96M 2.2%
60,000
TLT icon
16
iShares 20+ Year Treasury Bond ETF
TLT
$46B
$4.32M 1.92%
50,000
+30,000
+150% +$2.58M
IEF icon
17
iShares 7-10 Year Treasury Bond ETF
IEF
$43.3B
$3.31M 1.47%
35,000
DRAM
18
Roundhill Memory ETF
DRAM
$25.9B
$739K 0.33%
+10,000
New +$521K
COM icon
19
Direxion Auspice Broad Commodity Strategy ETF
COM
$212M
$489K 0.22%
+15,000
New +$506K
RSP icon
20
Invesco S&P 500 Equal Weight ETF
RSP
$99.6B
$426K 0.19%
2,000
-21,000
-91% -$4.3M
PRU icon
21
Prudential Financial
PRU
$42.2B
$290K 0.13%
2,683
BNO icon
22
United States Brent Oil Fund
BNO
$649M
-10,000
Closed -$520K
CORN icon
23
Teucrium Corn Fund
CORN
$171M
-27,000
Closed -$497K
IEMG icon
24
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
-15,000
Closed -$1.05M
MOO icon
25
VanEck Agribusiness ETF
MOO
$994M
-6,000
Closed -$507K

Similar funds

CVS Health's Q2 2026 Portfolio in Review

As of Q2 2026, CVS Health held 37 positions worth $225M, up 6.1% from $212M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

CVS Health deployed $12.4M of net new capital in Q2 2026, opening 4 new positions and adding to 7 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 70,000 shares worth $7.63M.

By sector, the portfolio is most concentrated in Financials at 0.13% of assets, up from 0.12% a quarter earlier.

On the sell side, the largest reduction was Invesco S&P 500 Equal Weight ETF, an estimated $4.3M trimmed.

  • CVS Health's largest Q2 2026 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 70,000 shares worth $7.63M.
  • CVS Health added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2026, an estimated $31.2M increase.
  • CVS Health's biggest Q2 2026 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $4.3M.
  • CVS Health fully exited State Street SPDR S&P 500 ETF Trust in Q2 2026, selling an estimated $57M.
  • CVS Health's ten largest holdings make up 84% of its $225M portfolio in Q2 2026.
  • CVS Health opened 4 new positions and closed 16 in Q2 2026.
  • CVS Health's portfolio value rose 6.1% quarter-over-quarter to $225M.

Based on CVS Health's 13F filing for Q2 2026, filed 6 Aug 2026.